{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:56:05Z","timestamp":1772823365311,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cll.2025.07.008","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T11:18:54Z","timestamp":1754911134000},"page":"643-655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hemostatic Disorders Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection, COVID-19 Vaccination, and Long-COVID Syndrome"],"prefix":"10.1016","volume":"45","author":[{"given":"Prakash","family":"Vishnu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Aboulafia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9215","key":"10.1016\/j.cll.2025.07.008_bib1","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)02225-X","article-title":"Blood coagulation","volume":"355","author":"Dahlb\u00e4ck","year":"2000","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.cll.2025.07.008_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2022.08.002","article-title":"Potential mechanisms of vaccine-induced thrombosis","volume":"105","author":"Marietta","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"3","key":"10.1016\/j.cll.2025.07.008_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019650","article-title":"Coronavirus disease 2019-Associated thrombosis and coagulopathy: review of the pathophysiological characteristics and implications for antithrombotic management","volume":"10","author":"Ortega-Paz","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.cll.2025.07.008_bib4","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jtha.2024.02.013","article-title":"Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?","volume":"22","author":"Iba","year":"2024","journal-title":"J Thromb Haemost JTH"},{"issue":"12","key":"10.1016\/j.cll.2025.07.008_bib5","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/17474086.2023.2288154","article-title":"Long-term hypercoagulability, endotheliopathy and inflammation following acute SARS-CoV-2 infection","volume":"16","author":"Boccatonda","year":"2023","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.cll.2025.07.008_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8671713","article-title":"Endothelial dysfunction, inflammation, and oxidative stress in COVID-19-Mechanisms and therapeutic targets","volume":"2021","author":"Fodor","year":"2021","journal-title":"Oxid Med Cell Longev"},{"issue":"12","key":"10.1016\/j.cll.2025.07.008_bib7","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00011-020-01401-6","article-title":"The coagulopathy, endotheliopathy, and vasculitis of COVID-19","volume":"69","author":"Iba","year":"2020","journal-title":"Inflamm Res"},{"issue":"5","key":"10.1016\/j.cll.2025.07.008_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100282","article-title":"Podoplanin and CLEC-2 levels in patients with COVID-19","volume":"7","author":"Borba-Junior","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"10.1016\/j.cll.2025.07.008_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2991\/chi.k.210117.001","article-title":"The many faces of cytokine release syndrome-related coagulopathy","volume":"3","author":"Wang","year":"2021","journal-title":"Clin Hematol Int"},{"issue":"4","key":"10.1016\/j.cll.2025.07.008_bib10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10456-021-09805-6","article-title":"COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects","volume":"24","author":"Smadja","year":"2021","journal-title":"Angiogenesis"},{"issue":"7","key":"10.1016\/j.cll.2025.07.008_bib11","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/jth.14872","article-title":"Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19","volume":"18","author":"Whyte","year":"2020","journal-title":"J Thromb Haemost JTH"},{"key":"10.1016\/j.cll.2025.07.008_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.thromres.2022.03.013","article-title":"Associations between hemostatic markers and mortality in COVID-19 - compounding effects of D-dimer, antithrombin and PAP complex","volume":"213","author":"Bokn\u00e4s","year":"2022","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.cll.2025.07.008_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1182\/blood.2021012247","article-title":"Clinical features of thrombosis and bleeding in COVID-19","volume":"140","author":"Thomas","year":"2022","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cll.2025.07.008_bib14","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s11239-020-02235-z","article-title":"Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis","volume":"50","author":"Hasan","year":"2020","journal-title":"J Thromb Thrombolysis"},{"issue":"3","key":"10.1016\/j.cll.2025.07.008_bib15","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.chest.2020.11.005","article-title":"Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis","volume":"159","author":"Jim\u00e9nez","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.cll.2025.07.008_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.avsg.2020.08.087","article-title":"Arterial thrombosis in coronavirus disease 2019 patients: a rapid systematic review","volume":"70","author":"Cheruiyot","year":"2021","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.cll.2025.07.008_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2021.02.010","article-title":"Incidence and impact of disseminated intravascular coagulation in COVID-19 a systematic review and meta-analysis","volume":"201","author":"Zhou","year":"2021","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.cll.2025.07.008_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-63078-9","article-title":"Disseminated intravascular coagulation is associated with poor prognosis in patients with COVID-19","volume":"14","author":"Gando","year":"2024","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.cll.2025.07.008_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3949\/ccjm.87a.ccc024","article-title":"Coagulopathy in COVID-19: manifestations and management","volume":"87","author":"Mucha","year":"2020","journal-title":"Cleve Clin J Med"},{"issue":"11","key":"10.1016\/j.cll.2025.07.008_bib20","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41577-021-00588-x","article-title":"Inflammasome activation at the crux of severe COVID-19","volume":"21","author":"Vora","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.cll.2025.07.008_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41577-021-00553-8","article-title":"Is IL-6 a key cytokine target for therapy in COVID-19?","volume":"21","author":"Jones","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"1159","key":"10.1016\/j.cll.2025.07.008_bib22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/postgradmedj-2021-139923","article-title":"Anticoagulation in COVID-19: current concepts and controversies","volume":"98","author":"Chandra","year":"2022","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.cll.2025.07.008_bib23","unstructured":"Coronavirus Disease 2019 (COVID-19) Treatment guidelines."},{"issue":"6","key":"10.1016\/j.cll.2025.07.008_bib25","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.jtha.2024.02.011","article-title":"2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19","volume":"22","author":"Schulman","year":"2024","journal-title":"J Thromb Haemost JTH"},{"issue":"9","key":"10.1016\/j.cll.2025.07.008_bib26","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/cts.13569","article-title":"Anticoagulant therapy in COVID-19: a narrative review","volume":"16","author":"Mohseni","year":"2023","journal-title":"Clin Transl Sci"},{"issue":"18","key":"10.1016\/j.cll.2025.07.008_bib27","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMsb2408466","article-title":"National academies of sciences, engineering, and medicine committee on examining the working definition for long covid. Long covid defined","volume":"391","author":"Ely","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cll.2025.07.008_bib28","article-title":"Understanding the long-term health effects of COVID-19","volume":"26","year":"2020","journal-title":"eClinicalMedicine"},{"issue":"1","key":"10.1016\/j.cll.2025.07.008_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ajh.26384","article-title":"Late-onset hematological complications post COVID-19: an emerging medical problem for the hematologist","volume":"97","author":"Korompoki","year":"2022","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.cll.2025.07.008_bib30","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.3390\/ijms24065514","article-title":"The long term residual effects of COVID-associated coagulopathy","volume":"24","author":"Ranucci","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cll.2025.07.008_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-069590","article-title":"Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study","volume":"377","author":"Katsoularis","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.cll.2025.07.008_bib32","doi-asserted-by":"crossref","DOI":"10.1097\/CRD.0000000000000552","article-title":"Cardiovascular manifestations of the long COVID syndrome","author":"Lorente-Ros","year":"2023","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.cll.2025.07.008_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102228","article-title":"Inflammation, immunity, and antigen persistence in post-acute sequelae of SARS-CoV-2 infectionImmunity and inflammaion in post-acute sequelae of SARS-CoV-2 infection","volume":"77","author":"Newell","year":"2022","journal-title":"Curr Opin Immunol"},{"issue":"10453","key":"10.1016\/j.cll.2025.07.008_bib34","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0140-6736(24)01136-X","article-title":"Long COVID: a clinical update","volume":"404","author":"Greenhalgh","year":"2024","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.cll.2025.07.008_bib35","article-title":"Long COVID: the nature of thrombotic sequelae determines the necessity of early anticoagulation","volume":"12","author":"Wang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"10.1016\/j.cll.2025.07.008_bib36","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamacardio.2022.1292","article-title":"Efficacy and safety considerations with dose-reduced direct oral anticoagulants: a review","volume":"7","author":"Bikdeli","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"22","key":"10.1016\/j.cll.2025.07.008_bib37","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.cll.2025.07.008_bib38","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.cll.2025.07.008_bib39","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/S2352-3026(21)00306-9","article-title":"Vaccine-induced immune thrombotic thrombocytopenia","volume":"9","author":"Klok","year":"2022","journal-title":"Lancet Haematol"},{"issue":"23","key":"10.1016\/j.cll.2025.07.008_bib40","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.cll.2025.07.008_bib41","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.cll.2025.07.008_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2022.101381","article-title":"Vaccine-induced immune thrombotic thrombocytopenia","volume":"35","author":"Kanack","year":"2022","journal-title":"Best Pract Res Clin Haematol"},{"issue":"2","key":"10.1016\/j.cll.2025.07.008_bib44","first-page":"130","article-title":"Antiplatelet therapy and outcome in COVID-19: the health outcome predictive evaluation registry","volume":"108","author":"Santoro","year":"2022","journal-title":"Heart Br Card Soc"},{"issue":"6","key":"10.1016\/j.cll.2025.07.008_bib45","article-title":"The IL-1\u03b2, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19","volume":"3","author":"Schulthei\u00df","year":"2022","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.cll.2025.07.008_bib46","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/15476286.2022.2100629","article-title":"Thrombosis-related circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19","volume":"19","author":"Eyileten","year":"2022","journal-title":"RNA Biol"},{"issue":"8","key":"10.1016\/j.cll.2025.07.008_bib47","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/jth.15409","article-title":"ADAMTS13 regulation of VWF multimer distribution in severe COVID-19","volume":"19","author":"Ward","year":"2021","journal-title":"J Thromb Haemost JTH"},{"key":"10.1016\/j.cll.2025.07.008_bib48","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.thromres.2021.09.017","article-title":"Long-term follow-up after successful treatment of vaccine-induced prothrombotic immune thrombocytopenia","volume":"207","author":"Thaler","year":"2021","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.cll.2025.07.008_bib49","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/v16020184","article-title":"Evolution of the SARS-CoV-2 omicron variants: genetic impact on viral fitness","volume":"16","author":"Liu","year":"2024","journal-title":"Viruses"},{"issue":"18","key":"10.1016\/j.cll.2025.07.008_bib50","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.3390\/jcm13185462","article-title":"Subsequent vaccination against SARS-CoV-2 after vaccine-induced immune thrombotic thrombocytopenia","volume":"13","author":"Uzun","year":"2024","journal-title":"J Clin Med"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271225000629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271225000629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:22:58Z","timestamp":1772803378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271225000629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0272271225000629"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2025.07.008","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemostatic Disorders Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection, COVID-19 Vaccination, and Long-COVID Syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2025.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}